SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and...

Por Allas, Soraya, Mohideen, Pharis, Delale, Thomas, Lin, Vivian, Tremel, Nadege, Yeh, Michael, Tauber, Maithe
Publicado no J Endocr Soc (2019)